Atrovent Pressurized Inhalation, Solution 17Mcg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Atrovent: Pressurized inhalation, solution (17mcg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Atrovent HFA 17mcg/act Inhaler

What is this Medicine?

IPRATROPIUM (i pra TROE pee um) is a bronchodilator. It helps open up the airways in your lungs to make it easier to breathe. This medicine is used to treat chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. Do not use this medicine for an acute attack.

CVS Pharmacy Patient Statistics for Atrovent: Pressurized inhalation, solution(17mcg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Atrovent HFA 17mcg/actuation Inhalation Aerosol

NDC: 005970087
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Bronchospasm Prophylaxis

Sometimes used for but not FDA approved for the following conditions:
Acute Bronchospasm, Exercise-induced Bronchospasm Prophylaxis, Asthma

Storage Information
For best results, product should be at room temperature before use
Exposure to temperatures above 120 degrees F may cause bursting
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Atrovent HFA 17mcg/actuation Inhalation Aerosol

Reported Side Effects for Atrovent HFA 17mcg/actuation Inhalation Aerosol

Breathing Difficulties Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Conjunctivitis Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Metallic Taste Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Hoarseness Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Rhinitis Incidence:
<3.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<3.0%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
<4.1%*
Severity: MILD
Onset: EARLY
Constipation Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Loose Stools Incidence:
<1.8%*
Severity: MILD
Onset: EARLY
Headache Incidence:
<7.0%*
Severity: MILD
Onset: EARLY
Inability To Sleep Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Shaking Incidence:
<1.0%*
Severity: MILD
Onset: EARLY
Retaining Urine Incidence:
<3.0%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
<3.0%*
Severity: MILD
Onset: RAPID
Dry Mouth Incidence:
<4.1%*
Severity: MILD
Onset: EARLY
Cough Incidence:
>0.1%*
Severity: MILD
Onset: DELAYED
Sinus Infection Incidence:
1.0-2.8%*
Severity: MILD
Onset: DELAYED
Upset Stomach Incidence:
1.0-5.0%*
Severity: MILD
Onset: EARLY
Sore Throat Incidence:
3.0-5.0%*
Severity: MILD
Onset: DELAYED
Chest Pain Incidence:
3.2%*
Severity: MODERATE
Onset: EARLY
Back Pain Incidence:
3.2-7.0%*
Severity: MILD
Onset: DELAYED
Shortness Of Breath Incidence:
8.0-10.0%*
Severity: MODERATE
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Atrovent

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.